• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白酶激活受体-1(PAR-1)和基质金属蛋白酶-1(MMP-1)在胃癌中的预后价值

Prognostic value of protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1) in gastric cancer.

作者信息

Fujimoto Daisuke, Hirono Yasuo, Goi Takanori, Katayama Kanji, Yamaguchi Akio

机构信息

First Department of Surgery, Faculty of Medicine, University of Fukui, Fukui 910-1193, Japan.

出版信息

Anticancer Res. 2008 Mar-Apr;28(2A):847-54.

PMID:18507028
Abstract

BACKGROUND

Protease-activated receptors (PARs) are proposed to be involved in the invasive and metastatic processes of various types of cancer. Matrix metalloproteinase-1 (MMP-1) plays a role in cancer invasion and tissue remodelling. It has been reported that MMP-1 can alter the behavior of cancer cells through PAR-1 to promote cell migration and invasion. We considered whether the expression of PAR-1 and MMP-1 has relevance to progression in gastric cancer.

MATERIALS AND METHODS

An immunohistochemical study was carried out on 129 samples of gastric cancer using anti-PAR-1 and anti-MMP-1 mouse monoclonal antibodies. Associations between immunostaining and clinicopathological factors were analyzed statistically.

RESULTS

There were 58 carcinomas positive for PAR-1 expression. The expression of PAR-1 was associated with the depth of wall invasion and peritoneal dissemination. There were 42 carcinomas positive for both PAR-1 and MMP-1 expression which was associated with the histological stage, depth of wall invasion, lymph node metastasis and peritoneal dissemination. These patients had a significantly poorer prognosis than those with expression-negative tumors. Multivariate analysis indicated that PAR-1 expression and combined PAR-1 and MMP-1 expression were independent prognostic factors.

CONCLUSION

The results led us to believe that the expression of PAR-1 and MMP-1 is associated with the progression of gastric cancer and an independent prognostic predictor.

摘要

背景

蛋白酶激活受体(PARs)被认为参与了各类癌症的侵袭和转移过程。基质金属蛋白酶-1(MMP-1)在癌症侵袭和组织重塑中发挥作用。据报道,MMP-1可通过PAR-1改变癌细胞行为,促进细胞迁移和侵袭。我们探讨了PAR-1和MMP-1的表达与胃癌进展是否相关。

材料与方法

使用抗PAR-1和抗MMP-1小鼠单克隆抗体对129例胃癌样本进行免疫组织化学研究。对免疫染色与临床病理因素之间的关联进行统计学分析。

结果

58例癌组织PAR-1表达呈阳性。PAR-1的表达与壁层浸润深度和腹膜播散有关。42例癌组织PAR-1和MMP-1表达均呈阳性,这与组织学分期、壁层浸润深度、淋巴结转移和腹膜播散有关。这些患者的预后明显比表达阴性肿瘤的患者差。多因素分析表明,PAR-1表达以及PAR-1和MMP-1联合表达是独立的预后因素。

结论

这些结果使我们相信,PAR-1和MMP-1的表达与胃癌进展相关,是独立的预后预测指标。

相似文献

1
Prognostic value of protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1) in gastric cancer.蛋白酶激活受体-1(PAR-1)和基质金属蛋白酶-1(MMP-1)在胃癌中的预后价值
Anticancer Res. 2008 Mar-Apr;28(2A):847-54.
2
Expression of protease activated receptor-2 (PAR-2) in gastric cancer.蛋白酶激活受体-2(PAR-2)在胃癌中的表达
J Surg Oncol. 2006 Feb 1;93(2):139-44. doi: 10.1002/jso.20420.
3
Correlation of lymph node metastases and expression of matrix metalloproteinase-7 in patients with gastric cancer.胃癌患者淋巴结转移与基质金属蛋白酶-7表达的相关性
Hepatogastroenterology. 2004 May-Jun;51(57):900-5.
4
Upregulation of matrix metalloproteinase-1 and proteinase-activated receptor-1 promotes the progression of human gliomas.基质金属蛋白酶-1 和蛋白酶激活受体-1 的上调促进了人类脑胶质瘤的进展。
Pathol Res Pract. 2011 Jan 15;207(1):24-9. doi: 10.1016/j.prp.2010.10.003. Epub 2010 Nov 18.
5
Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over-expression of matrilysin in human gastric cancer.ets相关转录因子E1AF的表达与人类胃癌的肿瘤进展及基质溶解素的过表达相关。
Carcinogenesis. 2004 Mar;25(3):325-32. doi: 10.1093/carcin/bgh011. Epub 2003 Nov 6.
6
The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: an immunohistochemical study of tissue microarrays.MUC-1在日本胃癌中的临床病理及预后意义:组织芯片的免疫组化研究
Anticancer Res. 2008 Mar-Apr;28(2A):1061-7.
7
Correlation between MMP1-PAR1 axis and clinical outcome of primary gallbladder carcinoma.MMP1-PAR1 轴与原发性胆囊癌临床结果的相关性。
Jpn J Clin Oncol. 2011 Sep;41(9):1086-93. doi: 10.1093/jjco/hyr108. Epub 2011 Aug 10.
8
PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells.PAR1是一种基质金属蛋白酶-1受体,可促进乳腺癌细胞的侵袭和肿瘤发生。
Cell. 2005 Feb 11;120(3):303-13. doi: 10.1016/j.cell.2004.12.018.
9
Associations of matrix metalloproteinase-9 protein polymorphisms with lymph node metastasis but not invasion of gastric cancer.基质金属蛋白酶-9蛋白多态性与胃癌淋巴结转移而非侵袭的相关性。
Clin Cancer Res. 2008 May 1;14(9):2870-7. doi: 10.1158/1078-0432.CCR-07-4042.
10
Amplification of MMP-2 and MMP-9 production by prostate cancer cell lines via activation of protease-activated receptors.前列腺癌细胞系通过蛋白酶激活受体的激活来放大基质金属蛋白酶-2和基质金属蛋白酶-9的产生。
Prostate. 2004 Jul 1;60(2):168-74. doi: 10.1002/pros.20047.

引用本文的文献

1
Prognostic Protein Biomarker Screening for Thyroid Carcinoma Based on Cancer Proteomics Profiles.基于癌症蛋白质组学图谱的甲状腺癌预后蛋白质生物标志物筛选
Biomedicines. 2024 Sep 10;12(9):2066. doi: 10.3390/biomedicines12092066.
2
Plasma Matrix Metalloproteinase-1 as a Prognostic Biomarker in Oral Cavity Squamous Cell Carcinoma.血浆基质金属蛋白酶-1作为口腔鳞状细胞癌的预后生物标志物
Cancer Manag Res. 2022 Dec 15;14:3459-3468. doi: 10.2147/CMAR.S389742. eCollection 2022.
3
Construction and validation of a novel coagulation-related 7-gene prognostic signature for gastric cancer.
一种新型胃癌凝血相关7基因预后标志物的构建与验证
Front Genet. 2022 Aug 29;13:957655. doi: 10.3389/fgene.2022.957655. eCollection 2022.
4
Role of Microglia and Astrocytes in Spinal Cord Injury Induced Neuropathic Pain.小胶质细胞和星形胶质细胞在脊髓损伤诱导的神经性疼痛中的作用。
Ann Neurosci. 2021 Jul;28(3-4):219-228. doi: 10.1177/09727531211046367. Epub 2021 Oct 18.
5
PAR1 and PAR4 exert opposite effects on tumor growth and metastasis of esophageal squamous cell carcinoma via STAT3 and NF-κB signaling pathways.蛋白酶激活受体1(PAR1)和蛋白酶激活受体4(PAR4)通过信号转导和转录激活因子3(STAT3)及核因子κB(NF-κB)信号通路对食管鳞状细胞癌的肿瘤生长和转移发挥相反作用。
Cancer Cell Int. 2021 Nov 29;21(1):637. doi: 10.1186/s12935-021-02354-4.
6
Matrix metalloproteinase‑1 expression is regulated by HIF‑1‑dependent and epigenetic mechanisms and serves a tumor‑suppressive role in gastric cancer progression.基质金属蛋白酶-1 的表达受 HIF-1 依赖性和表观遗传机制的调节,在胃癌进展中发挥肿瘤抑制作用。
Int J Oncol. 2021 Dec;59(6). doi: 10.3892/ijo.2021.5282. Epub 2021 Nov 5.
7
A KLK4 proteinase substrate capture approach to antagonize PAR1.KLK4 蛋白酶底物捕获方法拮抗 PAR1。
Sci Rep. 2021 Aug 9;11(1):16170. doi: 10.1038/s41598-021-95666-4.
8
Verification of Saliva Matrix Metalloproteinase-1 as a Strong Diagnostic Marker of Oral Cavity Cancer.唾液基质金属蛋白酶-1作为口腔癌强诊断标志物的验证
Cancers (Basel). 2020 Aug 13;12(8):2273. doi: 10.3390/cancers12082273.
9
Effects of vascular endothelial growth factor and epidermal growth factor on biological properties of gastric cancer cells.血管内皮生长因子和表皮生长因子对胃癌细胞生物学特性的影响。
Arch Med Sci. 2019 Oct;15(6):1498-1509. doi: 10.5114/aoms.2019.88443. Epub 2019 Oct 7.
10
Antithrombotic Agents and Cancer.抗血栓药物与癌症
Cancers (Basel). 2018 Jul 31;10(8):253. doi: 10.3390/cancers10080253.